Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Red blood cell alloimmunization and minor red blood cell antigen phenotypes in transfused Ghanaian patients with sickle cell disease.

Boateng LA, Campbell AD, Davenport RD, Osei-Akoto A, Hugan S, Asamoah A, Schonewille H.

Transfusion. 2019 Feb 13. doi: 10.1111/trf.15197. [Epub ahead of print]

PMID:
30758856
2.

Exposure to non-inherited maternal antigens by breastfeeding affects antibody responsiveness.

Schonewille H, van Rood JJ, Verduin EP, van de Watering LMG, Haasnoot GW, Claas FHJ, Oepkes D, Lopriore E, Brand A.

Haematologica. 2019 Feb;104(2):263-268. doi: 10.3324/haematol.2018.199406. Epub 2018 Sep 13.

3.

A Conceptual Framework for Optimizing Blood Matching Strategies: Balancing Patient Complications Against Total Costs Incurred.

van Sambeeck JHJ, de Wit PD, Luken J, Veldhuisen B, van den Hurk K, van Dongen A, Koopman MMW, van Kraaij MGJ, van der Schoot CE, Schonewille H, de Kort WLAM, Janssen MP.

Front Med (Lausanne). 2018 Jul 25;5:199. doi: 10.3389/fmed.2018.00199. eCollection 2018.

4.

D antibodies in pregnant women in multiethnic Suriname: the observational RheSuN study.

Zonneveld R, Kanhai HHH, Lamers M, Brand A, Zijlmans WCWR, Schonewille H.

Transfusion. 2017 Oct;57(10):2490-2495. doi: 10.1111/trf.14235. Epub 2017 Jul 13.

PMID:
28703855
5.

Prevalence of positive direct antiglobulin test and clinical outcomes in Surinamese newborns from D-negative women.

Zonneveld R, Lamers M, Schonewille H, Brand A, Kanhai HHH, Zijlmans WCWR.

Transfusion. 2017 Oct;57(10):2496-2501. doi: 10.1111/trf.14229. Epub 2017 Jul 5.

PMID:
28681433
6.

Blood Group Antigen Matching Influence on Gestational Outcomes (AMIGO) study.

Delaney M, Wikman A, van de Watering L, Schonewille H, Verdoes JP, Emery SP, Murphy MF, Staves J, Flach S, Arnold DM, Kaufman RM, Ziman A, Harm SK, Fung M, Eppes CS, Dunbar NM, Buser A, Meyer E, Savoia H, Abeysinghe P, Heddle N, Tinmouth A, Traore AN, Yazer MH; BEST Collaborative.

Transfusion. 2017 Mar;57(3):525-532. doi: 10.1111/trf.13977. Epub 2017 Feb 5.

PMID:
28164304
7.

RhIg-prophylaxis is not influenced by FCGR2/3 polymorphisms involved in red blood cell clearance.

Stegmann TC, Veldhuisen B, Nagelkerke SQ, Winkelhorst D, Schonewille H, Verduin EP, Kuijpers TW, de Haas M, Vidarsson G, van der Schoot CE.

Blood. 2017 Feb 23;129(8):1045-1048. doi: 10.1182/blood-2016-05-716365. Epub 2017 Jan 12. No abstract available.

8.

Red-blood-cell alloimmunisation in relation to antigens' exposure and their immunogenicity: a cohort study.

Evers D, Middelburg RA, de Haas M, Zalpuri S, de Vooght KM, van de Kerkhof D, Visser O, Péquériaux NC, Hudig F, Schonewille H, Zwaginga JJ, van der Bom JG.

Lancet Haematol. 2016 Jun;3(6):e284-92. doi: 10.1016/S2352-3026(16)30019-9. Epub 2016 May 9.

PMID:
27264038
9.

The HLA-DRB1*15 phenotype is associated with multiple red blood cell and HLA antibody responsiveness.

Verduin EP, Brand A, van de Watering LM, Roelen DL, Kanhai HH, Doxiadis II, Claas FH, Schonewille H.

Transfusion. 2016 Jul;56(7):1849-56. doi: 10.1111/trf.13648. Epub 2016 May 17.

PMID:
27185287
10.

Incidence of alloantibody formation after ABO-D or extended matched red blood cell transfusions: a randomized trial (MATCH study).

Schonewille H, Honohan Á, van der Watering LM, Hudig F, Te Boekhorst PA, Koopman-van Gemert AW, Brand A.

Transfusion. 2016 Feb;56(2):311-20. doi: 10.1111/trf.13347. Epub 2015 Oct 7.

PMID:
26442648
11.

Health-Related Quality of Life and Behavioral Functioning after Intrauterine Transfusion for Alloimmune Anemia.

van Klink JM, Lindenburg IT, Inklaar MJ, Verduin E, Koopman HM, van Kamp IL, Schonewille H, Oepkes D, Lopriore E; Long-Term Follow-Up after Intra-Uterine Transfusions Study Group.

J Pediatr. 2015 Nov;167(5):1130-5.e2. doi: 10.1016/j.jpeds.2015.07.065. Epub 2015 Sep 3.

PMID:
26342721
12.

Extended matched intrauterine transfusions reduce maternal Duffy, Kidd, and S antibody formation.

Schonewille H, Prinsen-Zander KJ, Reijnart M, van de Watering L, Zwaginga JJ, Meerman RH, van Kamp IL, Brand A.

Transfusion. 2015 Dec;55(12):2912-9; quiz 2911. doi: 10.1111/trf.13231. Epub 2015 Jul 14.

PMID:
26173835
13.

Female sex of older patients is an independent risk factor for red blood cell alloimmunization after transfusion.

Verduin EP, Brand A, Middelburg RA, Schonewille H.

Transfusion. 2015 Jun;55(6 Pt 2):1478-85. doi: 10.1111/trf.13111. Epub 2015 Apr 6.

PMID:
25846865
14.

A new preparation method for red blood cells for intrauterine transfusion enabling reduction of donor exposure.

Bontekoe IJ, Scharenberg J, Schonewille H, Zwaginga JJ, Brand A, van der Meer PF, de Korte D.

Transfusion. 2015 Jul;55(7):1693-9. doi: 10.1111/trf.13020. Epub 2015 Feb 5.

PMID:
25656421
15.

Anti-K formation is not associated with the storage time of transfused red blood cells.

Hogervorst E, Middelburg R, Brand A, van de Watering L, Schonewille H.

Transfusion. 2015 Jun;55(6 Pt 2):1472-7. doi: 10.1111/trf.12974. Epub 2015 Jan 9.

PMID:
25573120
16.

Factors associated with persistence of red blood cell antibodies in woman after pregnancies complicated by fetal alloimmune haemolytic disease treated with intrauterine transfusions.

Verduin EP, Brand A, van de Watering LM, Claas FH, Oepkes D, Lopriore E, Doxiadis II, Schonewille H.

Br J Haematol. 2015 Feb;168(3):443-51. doi: 10.1111/bjh.13130. Epub 2014 Sep 22.

PMID:
25244566
17.

Immunosuppressants and alloimmunization against red blood cell transfusions.

Zalpuri S, Evers D, Zwaginga JJ, Schonewille H, de Vooght KM, le Cessie S, van der Bom JG.

Transfusion. 2014 Aug;54(8):1981-7. doi: 10.1111/trf.12639. Epub 2014 Apr 1.

PMID:
24689865
18.

HLA-DRB1 associations in individuals with single and multiple clinically relevant red blood cell antibodies.

Schonewille H, Doxiadis II, Levering WH, Roelen DL, Claas FH, Brand A.

Transfusion. 2014 Aug;54(8):1971-80. doi: 10.1111/trf.12624. Epub 2014 Mar 24.

PMID:
24654685
19.

Intensive red blood cell transfusions and risk of alloimmunization.

Zalpuri S, Middelburg RA, Schonewille H, de Vooght KM, le Cessie S, van der Bom JG, Zwaginga JJ.

Transfusion. 2014 Feb;54(2):278-84. doi: 10.1111/trf.12312. Epub 2013 Jun 19.

PMID:
23782244
20.

Comparison of different blood sample processing methods for sensitive detection of low level chimerism by RHD real-time PCR assay.

Javadi A, Verduin EP, Brand A, Schonewille H.

Chimerism. 2013 Jan-Mar;4(1):9-14. doi: 10.4161/chim.24248. Epub 2013 Jan 1.

21.

Effect of storage of red blood cells on alloimmunization.

Zalpuri S, Schonewille H, Middelburg R, van de Watering L, de Vooght K, Zimring J, van der Bom JG, Zwaginga JJ.

Transfusion. 2013 Nov;53(11):2795-800. doi: 10.1111/trf.12156. Epub 2013 Mar 11.

PMID:
23480520
22.

High anti-HLA response in women exposed to intrauterine transfusions for severe alloimmune hemolytic disease is associated with mother-child HLA triplet mismatches, high anti-D titer, and new red blood cell antibody formation.

Verduin EP, Schonewille H, Brand A, Haasnoot GW, Claas FH, Lindenburg IT, Lopriore E, Oepkes D, Roelen DL, Doxiadis II.

Transfusion. 2013 May;53(5):939-47. doi: 10.1111/j.1537-2995.2012.03862.x. Epub 2012 Aug 23.

PMID:
22924899
23.

Is female sex a risk factor for red blood cell alloimmunization after transfusion? A systematic review.

Verduin EP, Brand A, Schonewille H.

Transfus Med Rev. 2012 Oct;26(4):342-53, 353.e1-5. doi: 10.1016/j.tmrv.2011.12.001. Epub 2012 Jan 13. Review.

PMID:
22244869
24.

Long-term neurodevelopmental outcome after intrauterine transfusion for hemolytic disease of the fetus/newborn: the LOTUS study.

Lindenburg IT, Smits-Wintjens VE, van Klink JM, Verduin E, van Kamp IL, Walther FJ, Schonewille H, Doxiadis II, Kanhai HH, van Lith JM, van Zwet EW, Oepkes D, Brand A, Lopriore E; LOTUS study group.

Am J Obstet Gynecol. 2012 Feb;206(2):141.e1-8. doi: 10.1016/j.ajog.2011.09.024. Epub 2011 Sep 24.

25.

Red-blood-cell alloimmunization and number of red-blood-cell transfusions.

Zalpuri S, Zwaginga JJ, le Cessie S, Elshuis J, Schonewille H, van der Bom JG.

Vox Sang. 2012 Feb;102(2):144-9. doi: 10.1111/j.1423-0410.2011.01517.x. Epub 2011 Jul 6.

PMID:
21729098
26.

Maternal red blood cell alloimmunisation in south western Uganda.

Natukunda B, Mugyenyi G, Brand A, Schonewille H.

Transfus Med. 2011 Aug;21(4):262-6. doi: 10.1111/j.1365-3148.2011.01073.x. Epub 2011 Mar 3.

PMID:
21371143
27.

Long-Term follow up after intra-Uterine transfusionS; the LOTUS study.

Verduin EP, Lindenburg IT, Smits-Wintjens VE, van Klink JM, Schonewille H, van Kamp IL, Oepkes D, Walther FJ, Kanhai HH, Doxiadis II, Lopriore E, Brand A.

BMC Pregnancy Childbirth. 2010 Dec 1;10:77. doi: 10.1186/1471-2393-10-77.

28.

Red blood cell alloimmunization from an African perspective.

Natukunda B, Brand A, Schonewille H.

Curr Opin Hematol. 2010 Nov;17(6):565-70. doi: 10.1097/MOH.0b013e32833ec54b. Review.

PMID:
20827185
29.

Assessment of the clinical transfusion practice at a regional referral hospital in Uganda.

Natukunda B, Schonewille H, Smit Sibinga CT.

Transfus Med. 2010 Jun;20(3):134-9. doi: 10.1111/j.1365-3148.2010.00992.x. Epub 2010 Feb 1.

PMID:
20136779
30.

Red blood cell alloimmunization in sickle cell disease patients in Uganda.

Natukunda B, Schonewille H, Ndugwa C, Brand A.

Transfusion. 2010 Jan;50(1):20-5. doi: 10.1111/j.1537-2995.2009.02435.x. Epub 2009 Oct 10.

PMID:
19821949
31.

Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases.

Natukunda B, Schonewille H, van de Watering L, Brand A.

Vox Sang. 2010 Feb;98(2):167-71. doi: 10.1111/j.1423-0410.2009.01241.x. Epub 2009 Aug 24.

PMID:
19708889
32.

Alloimmune response after additional red blood cell antigen challenge in immunized hematooncology patients.

Schonewille H, de Vries RR, Brand A.

Transfusion. 2009 Mar;49(3):453-7. doi: 10.1111/j.1537-2995.2008.01980.x.

PMID:
19243541
33.

Does an alloimmune response to strong immunogenic red blood cell antigens enhance a response to weaker antigens?

Schonewille H, Brand A.

Transfusion. 2008 May;48(5):958-63. doi: 10.1111/j.1537-2995.2008.01659.x.

PMID:
18454736
34.

High additional maternal red cell alloimmunization after Rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus.

Schonewille H, Klumper FJ, van de Watering LM, Kanhai HH, Brand A.

Am J Obstet Gynecol. 2007 Feb;196(2):143.e1-6.

PMID:
17306657
35.

Prevalence of HLA antibodies in transfused patients with and without red blood cell antibodies.

Schonewille H, van de Watering LM.

Transfusion. 2007 Feb;47(2):357-8; author reply 358. No abstract available.

PMID:
17302788
36.

Prevention and diagnosis of delayed haemolytic transfusion reactions.

Engelfriet CP, Reesink HW, Fontão-Wendel R, Lazar A, Cardoso RA, Olyntho S, Achkar R, Wendel S, Pisacka M, Taaning E, Koski T, Matilainen J, Kretschmer V, Karger R, Politis C, Katsea P, Malamou V, Aprili G, Piccoli P, Gandini G, Franchini M, Schonewille H, Brand A, Solheim BG, Flesland O, Seyfried H, Michalewska B, Letowska M, Tissot JD, Milkins C, Knowles S, DeSilva M, Contreras M, Stainsby D, Combs MR, Arney RS, Telen MJ.

Vox Sang. 2006 Nov;91(4):353-68. No abstract available.

PMID:
17105616
37.
38.

Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity.

Schonewille H, van de Watering LM, Loomans DS, Brand A.

Transfusion. 2006 Feb;46(2):250-6.

PMID:
16441603
39.

[Pathophysiology and treatment of sickle-cell disease].

Beckers EA, Schonewille H, Kerkhoffs JL.

Ned Tijdschr Geneeskd. 2005 Sep 3;149(36):2024; author reply 2024. Dutch. No abstract available.

PMID:
16171118
40.
41.

The importance of antibodies against low-incidence RBC antigens in complete and abbreviated cross-matching.

Schonewille H, van Zijl AM, Wijermans PW.

Transfusion. 2003 Jul;43(7):939-44.

PMID:
12823754
42.

RBC antibody persistence.

Schonewille H, Haak HL, van Zijl AM.

Transfusion. 2000 Sep;40(9):1127-31.

PMID:
10988317
43.

Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases.

Schonewille H, Haak HL, van Zijl AM.

Transfusion. 1999 Jul;39(7):763-71.

PMID:
10413286
44.

The effect of anticoagulants on the size of platelets in blood smears in the course of time.

Schonewille H, Haak HL, Kerkhofs H, Gerrits WB.

Clin Lab Haematol. 1991;13(1):67-74.

PMID:
1905604
45.

Significance of in vitro cultures in myelodysplastic syndromes.

Haak HL, Kerkhofs H, van der Linden JS, Schonewille H, van der Sanden-van der Meer HS, Hermans J.

Scand J Haematol. 1986 Nov;37(5):380-9.

PMID:
3492752

Supplemental Content

Loading ...
Support Center